Contact Information

160 Robinson Rd, #14-04
Sit Rd, SBF Center, Singapore 068914

ThinkSono, a UK-German medtech company specializing in ultrasound guidance solutions, has secured £2.1 million in its latest funding round, bringing its total raised funds to approximately £5 million to date.

  • Investors: The latest funding round was led by id4 ventures, with participation from Brandenburg Kapital, Calm Storm Ventures, Dubai Angel Investors, CrowdCube, Cur8 Capital, and multiple prominent angel investors and clinicians in vascular surgery.
  • Flagship Product: ThinkSono’s flagship product, Sono Guidance, utilizes AI and real-time imaging technology to enhance accuracy and precision during ultrasound-guided procedures.
  • Clinical Application: Sono Guidance enables non-ultrasound-trained healthcare staff to scan patients suspected of blood clots (DVT) and send the data for qualified clinician review, thus improving the clinical pathway for DVT diagnosis, a leading cause of preventable hospital death worldwide.
  • CEO Statement: Fouad Al Noor, CEO and Founder of ThinkSono, expressed excitement about the funding milestone and regulatory achievements, highlighting the company’s mission to revolutionize medical imaging technology.

ThinkSono has partnered with hospitals across Europe, including the UK, Germany, and Greece. It has also formed strategic partnerships with NYU Langone Health and Temple Health in the US as part of its pursuit of FDA approval.

client banner image
Share:

Leave a Reply

Your email address will not be published. Required fields are marked *